Evidence map›Paper›PMID 33804793›Full record

ReviewAnimals : an open access journal from MDPI2021

Cannabis, Cannabidiol Oils and Tetrahydrocannabinol-What Do Veterinarians Need to Know?

Nancy De Briyne, Danny Holmes, Ian Sandler, Enid Stiles, Dharati Szymanski, Sarah Moody, Stephan Neumann, Arturo Anadón

Open access · goldAbstract readReview
In one paragraph

Review in Animals : an open access journal from MDPI, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Pharmacokinetics of cannabidiol, (-)-Frontiers in veterinary science · 2025
    Article
  6. Article
  7. The Canadian veterinary journal = La revue veterinaire canadienne · 2024
    Review
  8. Safety study of cannabidiol products in healthy dogs.Frontiers in veterinary science · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 5 countries.

Nancy De BriyneFederation of Veterinarians of Europe (FVE), 1040 Brussels, Belgium.ORCID 0000-0002-2348-930X
Danny HolmesHolmes St Anthony's Veterinary Hospital, St Anthonys, Caherslee, V92 V6YK Tralee, Ireland.
Ian SandlerCanadian Veterinary Medical Association (CVMA), Ottawa, ON K1R 7K1, Canada.
Enid StilesCanadian Veterinary Medical Association (CVMA), Ottawa, ON K1R 7K1, Canada.
Dharati SzymanskiAmerican Veterinary Medical Association (AVMA), Schaumburg, IL 60173, USA.
Sarah MoodyFederation of Veterinarians of Europe (FVE), 1040 Brussels, Belgium.
Stephan NeumannCompanion Animal Clinic, Institute of Veterinary Medicine, University of Goettingen, 37073 Göttingen, Germany.
Arturo AnadónDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Canadian Veterinary Medical Association · CAFrench Community of Belgium · BEAmerican Veterinary Medical Association · USUniversidad Complutense de Madrid · ESUniversity of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As cannabis-derived products have become more available, veterinarians are seeing more cases of toxicosis. In addition, animal owners are having an increasing interest in using these products for their pets. This review looks at the situation in Europe and North America, the different types of cannabis and cannabis-derived products with historical examples of use in animals, and the cannabis industry. The existing regulatory framework for use in humans and animals as medicines and/or supplements was examined. Finally, a review of the clinical indications for which medicinal cannabis is authorised, a discussion of toxicosis, and recommendations and warnings around medical cannabis use are presented.

Indexed as

cannabidiol (CBD)cannabinoidscannabiscatCBD oilscompanion animalsdoghorseMarinolTHC (Delta-9-trans tetrahydrocannabinol or tetrahydrocannabinol)toxicityveterinary medicineveterinary use

Identifiers

PMID33804793
PMCPMC8003882
OpenAlexW3136719642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.